<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR31">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>Schmidt</surname>
    <given-names>AP</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>GM</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Wooters</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells</article-title>
  <source>J Exp Med</source>
  <year>2000</year>
  <volume>192</volume>
  <issue>7</issue>
  <fpage>1069</fpage>
  <lpage>1074</lpage>
  <pub-id pub-id-type="doi">10.1084/jem.192.7.1069</pub-id>
  <pub-id pub-id-type="pmid">11015447</pub-id>
 </element-citation>
</ref>
